| [1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
| [2] |
WANG Anjing, WANG Yaya, LIANG Xuan, YAN Yajie, SU Jing, LI Caidong.
Research progress on mechanisms and therapeutic drugs of peroxisome proliferator-activated receptor in treatment of cholestatic liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 796-808.
|
| [3] |
MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling.
Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
|
| [4] |
LIU Wenjing, WU Zhitao, PAN Guoyu.
Early dectection and prediction hepatotoxic risk in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 923-930.
|
| [5] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
| [6] |
SONG Ruzheng, PENG Ying, WANG Guangji, SUN Jianguo.
Commonly used quantitative proteomics research techniques and their application in the study of pathogenesis of liver-derived diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 570-578.
|
| [7] |
XU Lina, LI Yue, PENG Jinyong.
microRNA and drug-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 803-809.
|
| [8] |
YU Han, ZHONG Xianggen, LI Yunzhou, XU Zongying, SHI Shaohua, DENG Xiulan.
Effects of melatonin on NO, MDA, GSH and NADPH expression in liver tissues of intrahepatic cholestasis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1221-1226.
|
| [9] |
WU Jiayuan, ZHENG Li, MO Juanfen, GUO Li, CAO Chenxi, BAO Yi.
Regulation of N-acetylcysteine on peripheral circulatory and hepatic myeloid-derived suppressor cells in non-alcoholic fatty liver disease mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 989-996.
|
| [10] |
MAO Yun, ZHANG Zhaorui.
Effects of ginsenoside-induced bone marrow mesenchymal stem cells on liver regeneration and Wnt/β-catenin signaling in rats with acute liver failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 503-510.
|
| [11] |
ZHENG Qiongna, WU Qiaoqiao, MA Zhele, ZHANG Xianfei, GAN Fangmin, KONG Qingming.
Interventional effect of low molecular weight heparin on mice with experimental hepatic fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 511-516.
|
| [12] |
QI Yong，ZHANG Song， LU Caide.
Application research of tranexamic acid combined with low central venous pressure during liver transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 307-312.
|
| [13] |
WANG Yanhong, FENG Tiexin, PU Junfeng, ZHANG Lingfang, LI Hongling.
Protective effects of manganese superoxide dismutase mimic on liver injury in mice induced by carbon tetrachloride
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1209-1214.
|
| [14] |
WANG Lu, LI Liping, XING Xin, XU Dengqiu, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin.
Hepatic macrophages in liver injury and repair
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1188-1195.
|
| [15] |
ZENG Chuanli, HU Airong, HU Yaoren, YUAN Gang, ZHU Dedong, SHI Xiaojun.
Clinical effect of entecavir combined with probiotics on treatment of patients with hepatitis B cirrhosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 796-801.
|
